UNSPSC 51111877: Enzalutamide
Commodity
Code facts
- Part of
-
-
51000000
-
51110000
- 51111800
-
51110000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51111877
| NIGP code |
|---|
| 26910 Antineoplastic Agents |
Definition
An androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-resistant prostate cancer.
About UNSPSC 51111877
UNSPSC 51111877 Enzalutamide is a Commodity code covering procurement of this specific oncology pharmaceutical, used by state and local health systems, departments of corrections, and public health agencies to treat advanced prostate cancer in patients under their care. The drug is dispensed through institutional pharmacy procurement channels, typically as part of formulary acquisitions or disease-management protocols within public healthcare systems.
The source provided contains no recent state or local contract opportunities under this code. Without posted solicitations, issuing-body patterns, geographic concentration, or representative recent procurements, direct market signals for this Commodity cannot be assessed at this time.
Quick answers
What is UNSPSC 51111877?
UNSPSC 51111877 is Enzalutamide, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51111877?
UNSPSC 51111877 maps to 1 NIGP code, 26910 Antineoplastic Agents.
On GovTribe
See everything under UNSPSC 51111877
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code